EN | PT

| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme T = 36 months |
|
| Bioequivalence study Performed in R&D Solution Reference product: Italian |
|
| Approved | PT, ES, IT |
| Available MA's | PT, IT, ES |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme Climatic Zone II T = 12 months Climatic Zone IVB T = 9 months |
End: 02/2013 |
| Bioequivalence study Performed in IPRC Reference product: Spain |
ongoing |
| Approved | - |
| Available MA's | - |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme | End: 11/2013 |
| Bioequivalence study Performed in Anapharm Reference product: France |
|
| Approved | NL, BG, CZ, EE, HU, LT, LV, PL, RO, SK, UK, BE, ES, IT, DE, EL, DK, FI, NO, SE, PT |
| Available MA's | NL, DE, FR, IT, CZ |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme | T=60 Months End: 12/2011 |
| Bioequivalence study Performed in Algorithme Pharma Reference product: France |
|
| Approved | PT, IT, ES, FR, DE, SE, NL, UK, AT, BE, HU, DK, FI, NO |
| Available MA's | AT, BE, DE, DK, ES, FI, FR, HU, IT, NL, NO, PT, SE, UK |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme T = 24 months |
|
| Bioequivalence study Performed in Algorithme Pharma Reference product: France |
|
| Approved | PT, ES |
| Available MA's | PT |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme | End: 8/2012 |
| Bioequivalence study Performed in Algorithme Pharma Reference product: DE and USA |
|
| Approved | PT |
| Available MA's | USA, UK, BE, DE, DK, EL, ES, FR, HU, IT, NO, PT, SE |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme | End: 4/2012 |
| Bioequivalence study Performed in Algorithme Pharma Reference product: DE |
|
| Approved | AU |
| Available MA's | Contact us |
Ask for further details by e-mail at business@bluepharma.pt
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme T = 36 months |
End: 08/2011 |
| Bioequivalence study Biowaiver |
|
| Approved | PT, ES, DE, FR, USA |
| Available MA's | PT |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme T = 36 months |
End: 09/2011 |
| Bioequivalence study Performed in Algorithme Pharma Reference product: France |
|
| Approved | PT, ES, FR, IT |
| Available MA's | PT, IT |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme | End: 11/2013 |
| Bioequivalence study Performed in Anapharm Reference product: France |
|
| Approved | NL, BG, CZ, EE, HU, LT, LV, PL, RO, SK, UK, BE, ES, IT, DE, EL, DK, FI, NO, SE, PT |
| Available MA's | NL, DE, FR, IT, CZ |
| Task | Status |
|---|---|
| Galenical development | |
| Development and validation of analytical methods | |
| Manufacturing and packaging of validation batches | |
| ICH stability programme | T=60 Months End: 8/2012 |
| Bioequivalence study Performed in ACC GmbH Reference product: France |
|
| Approved | PT, IT, ES, FR, DE, SE, NL, UK, AT, BE, HU, DK, FI, NO |
| Available MA's | AT, BE, DE, DK, ES, FI, FR, HU, IT, NL, NO, PT, SE, UK |
Nimesulide (new dossier)
Task Status Galenical development Development and validation of analytical methods Manufacturing and packaging of validation batches ICH stability programme
T = 24 monthsBioequivalence study
Reference product: Franceunder preparation Approved PT Available MA's - Irbesartan + HCTZ
Task Status Galenical development Development and validation of analytical methods Manufacturing and packaging of validation batches ICH stability programme End: 8/2012 Bioequivalence study
Performed in Algorithme Pharma
Reference product: DE and USAApproved - Available MA's USA, UK, BE, DE, DK, EL, ES, FR, HU, IT, NO, PT, SE Levetiracetam (oral solution)
Task Status Galenical development Development and validation of analytical methods Manufacturing and packaging of validation batches ICH stability programme Approved - Available MA's Contact us